Boston Scientific’s LOTUS valves off the market until at least 2019

Daniel Allar | | Cardiovascular Business | Structural Heart Disease

The LOTUS Edge Aortic Valve System will not be available in Europe or the U.S. until at least 2019, Boston Scientific CEO Mike Mahoney said during a Feb. 1 conference call with investors.

All LOTUS valves were voluntarily recalled in February 2017 due to an issue with its locking mechanism. Boston Scientific later announced plans to reintroduce the valves into the European marketplace had been pushed back, and now Mahoney is confirming they won’t be commercially available anywhere this year.

The CEO’s statement came as he discussed the company’s fourth quarter and full 2017 financial results. Boston Scientific generated sales of $2.41 billion during the fourth quarter, a 9.9 percent growth year over year. Full year sales were $9.05 billion, up from $8.39 billion in 2016.

"Our team delivered excellent fourth quarter and full year results, fueled by the strength of our diversified portfolio and global commercial execution," Mahoney said in a press release. "We look forward to building on our momentum and continuing to make a meaningful difference for patients in 2018."

""
Daniel Allar

Daniel joined TriMed’s Chicago editorial team in 2017 as a Cardiovascular Business writer. He previously worked as a writer for daily newspapers in North Dakota and Indiana.

Related Content

How TAVR valve choice impacts outcomes when treating type 1 bicuspid AS
Medtronic using AI to identify more TAVR patients in need
SAVR linked to higher 10-year survival rate than TAVR for low-risk patients
9 key takeaways from AHA 2024 in Chicago
Redo TAVR: The impact of implanting balloon-expandable valves in failed self-expanding valves
Edoxaban could limit blood clots, ‘make life easier’ for heart valve surgery patients

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."